![shutterstock_663878965 [Converted]_natur](https://static.wixstatic.com/media/169631_ffbf004190a041c893ffb10fc7018166~mv2.png/v1/fill/w_132,h_84,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/shutterstock_663878965%20%5BConverted%5D_natur.png)
![shutterstock_663878965 [Converted]_natur](https://static.wixstatic.com/media/169631_ffbf004190a041c893ffb10fc7018166~mv2.png/v1/fill/w_124,h_80,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/shutterstock_663878965%20%5BConverted%5D_natur.png)
.jpeg)
Colon and rectal cancer clinical research
COLORECTAL CANCER
Innovative research treatment for colon or rectal cancer patients undergoing surgery, to prevent cancer recurrence and prevent the development of cancer metastases.
The treatment is provided free of charge.
The drug treatment in the study is not a substitute for existing treatments.
Treatment begins 5 days before surgery and continues for about two weeks afterward.
The treatment is based on existing drugs marketed in Israel and internationally.
Further information
Medical centers where
The research is underway.
Shamir Medical Center (Asaf Harofeh), Tzirifin.
Principal Investigator: Prof. Oded Zamora.
Hadassah Medical Center, Jerusalem.
Principal Investigator: Dr. Noam Shusman.
Hasharon Medical Center, Petach Tikva.
Principal Investigator: Prof. Nidal Issa.
Who the research is not intended for
Patients who regularly consume beta-blocker or NSAID medications or are sensitive to these medications.
Patients with malignancy treated in the last 5 years
Patients with active asthma
Who the research is intended for
Patients diagnosed with praimery Colorectal cancer
at stages 1–3 (with no evidence of metastases)
Patients who are candidates for surgical tumor resection
Women and men aged 20 to 85
*A full examination regarding eligibility for the study will be conducted at the medical center.
When you arrive at your next appointment with your doctor, ask him/her about joining the study!
